| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | SVP, Regulatory Affairs And Qa
1 company
Jalota Deepika is a Chief Development Officer at PMV Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $128K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 33,065 | $1.06 | $35,197.69 | -26.9% | +38.1% | - | |
| Sep 11, 2024 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 7,218 | $1.50 | $10,852.98 | -5.8% | +6.0% | -18.5% | |
| Sep 15, 2023 | PMVP Pmv Pharmaceuticals, Inc. | Chief Development Officer | Sell | 4,104 | $6.62 | $27,168.48 | -12.1% | -66.0% | -77.5% | |
| Aug 17, 2021 | PMVP Pmv Pharmaceuticals, Inc. | SVP, Regulatory Affairs And Qa | Sale+OE | 2,896 | $33.78 | $97,814.14 | -100% | -30.7% | -55.6% |